Organon & Co. (NYSE:OGN) is one of the 13 Best Healthcare Stocks to Buy Under $10. On July 7, Organon & Co. (NYSE:OGN) announced that its VTAMA (tapinarof) cream, 1%, attained a strong recommendation ...

Arcutis Biotherapeutics Inc. (NASDAQ:ARQT) is one of the most promising stocks according to Wall Street analysts. On June 26, ...

As we age, our necks can make us look older, but now there’s a breakthrough. A new study shows using a topical, clinically studied cream can help improve the look of wrinkly, crepey skin on ...

Master the art of summer skincare layering with expert advice, barrier-boosting ingredients, and science-backed alternatives ...

Send comments and news tips to news@medscape.net. Cite this: FDA Extends Ruxolitinib Cream Review Period for Pediatric Atopic Dermatitis - Medscape - June 25, 2025.

Ruxolitinib cream is effective for atopic dermatitis and prurigo nodularis, with low adverse event rates in long-term use. The cream reduces the need for other topical treatments and biologics in ...

Key takeaways: Adults and children previously treated with Vtama cream 1% went through a treatment-free period of approximately 80 days. During that period, all patients maintained mild disease ...

Yellowjackets introduces us to a very, very weird ad with a phone number that gives us a fun and creepy message from an ice cream parlor.

The company launched a “We All Scream” campaign to introduce its new Coca-Cola Orange Cream and Coca-Cola Zero Sugar Orange Cream to a wider audience as it rolls out across retailers in the U ...

Vin Diesel, Michelle Rodriguez, and Ludacris all star in the first Super Bowl commercial for Häagen-Dazs ice cream, released ahead of Super Bowl LIX on Sunday.

Arcutis Biotherapeutics has submitted a supplemental new drug application to the FDA for Zoryve cream 0.05% for the treatment of pediatric mild to moderate atopic dermatitis, according to a press ...

Organon (OGN) announced that the U.S. Food and Drug Administration or FDA has approved VTAMA or tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, for an additional indication of the ...